Schloegl et al., 2012 - Google Patents
Porosity and mechanically optimized PLGA based in situ hardening systemsSchloegl et al., 2012
- Document ID
- 4553154753537041245
- Author
- Schloegl W
- Marschall V
- Witting M
- Volkmer E
- Drosse I
- Leicht U
- Schieker M
- Wiggenhorn M
- Schaubhut F
- Zahler S
- Friess W
- Publication year
- Publication venue
- European journal of pharmaceutics and biopharmaceutics
External Links
Snippet
Goal of the present study was to develop and to characterize in situ-hardening, porous PLGA-based systems for their future application as bone grafting materials. Therefore, we investigated the precipitation behavior of formulations containing PLGA and a water …
- 238000011065 in-situ storage 0 title abstract description 18
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yao et al. | Three dimensional electrospun PCL/PLA blend nanofibrous scaffolds with significantly improved stem cells osteogenic differentiation and cranial bone formation | |
JP5881669B2 (en) | Collagen / hydroxyapatite composite skeleton and method for producing the same | |
US10933167B2 (en) | Injectable scaffold composition and related methods | |
Laurencin et al. | Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications | |
Ryan et al. | Effect of different hydroxyapatite incorporation methods on the structural and biological properties of porous collagen scaffolds for bone repair | |
Deng et al. | Dipeptide-based polyphosphazene and polyester blends for bone tissue engineering | |
Liu et al. | Electrospun nanofibrous P (DLLA–CL) balloons as calcium phosphate cement filled containers for bone repair: in vitro and in vivo studies | |
Gyawali et al. | Citrate-based biodegradable injectable hydrogel composites for orthopedic applications | |
Chen et al. | The effect of surface area on the degradation rate of nano-fibrous poly (L-lactic acid) foams | |
Haberstroh et al. | Bone repair by cell‐seeded 3D‐bioplotted composite scaffolds made of collagen treated tricalciumphosphate or tricalciumphosphate‐chitosan‐collagen hydrogel or PLGA in ovine critical‐sized calvarial defects | |
Mintz et al. | Hybrid hyaluronic acid hydrogel/poly (ɛ‐caprolactone) scaffold provides mechanically favorable platform for cartilage tissue engineering studies | |
Kim et al. | 3D printed alendronate-releasing poly (caprolactone) porous scaffolds enhance osteogenic differentiation and bone formation in rat tibial defects | |
Park et al. | Calcium phosphate combination biomaterials as human mesenchymal stem cell delivery vehicles for bone repair | |
Baylan et al. | Polycaprolactone nanofiber interspersed collagen type-I scaffold for bone regeneration: a unique injectable osteogenic scaffold | |
Schloegl et al. | Porosity and mechanically optimized PLGA based in situ hardening systems | |
Liu et al. | PHBV and predifferentiated human adipose‐derived stem cells for cartilage tissue engineering | |
Chinnasami et al. | Three-dimensional scaffolds for bone tissue engineering | |
Reverchon et al. | Nanostructured PLLA− hydroxyapatite scaffolds produced by a supercritical assisted technique | |
Cui et al. | Fabrication and characterization of chitosan/OGP coated porous poly (ε-caprolactone) scaffold for bone tissue engineering | |
Kuterbekov et al. | Solvent-free preparation of porous poly (l-lactide) microcarriers for cell culture | |
Garber et al. | Thiol‐acrylate nanocomposite foams for critical size bone defect repair: A novel biomaterial | |
Minton et al. | Solvent-free polymer/bioceramic scaffolds for bone tissue engineering: fabrication, analysis, and cell growth | |
Ding et al. | Delivery of demineralized bone matrix powder using a salt-leached silk fibroin carrier for bone regeneration | |
Grosfeld et al. | Fast dissolving glucose porogens for early calcium phosphate cement degradation and bone regeneration | |
Jeon et al. | Tailoring of processing parameters for sintering microsphere‐based scaffolds with dense‐phase carbon dioxide |